Table 2

Immunohistochemical analysis of control and EL brain using anti-coxsackievirus antibody
Dilution 1:3,000 1:6,000 1:10,000 1:20,000 1:40,000 0 antibody
Neutralizing dose/ml 6.8 3.4 2 1 0.5 0
Controls, UK cases
06/112 1+ 2+ 2+ 0
06/110 2+ 0 0
06/126/7 1+
05/152-9 1+ 0
05/25- 1+ 0
05/47-11 0
NP86/07-4 0
05/137/5 1+
05/66-28 0
05-01-8 0
Controls, USA
865183-M 1+ 1+
8889C 2+ 0
8854127-13 0
883599-11 2+ 2+ 2+ 2+
1311056-17 1+
EL, USA Cases
21225A 3+ 2+ 2+ 0
21225B 2+ 3.5+ 2+
19940C 4+ 0.2+ 0 0
19940B 2.5+ 4+ 3+ 0 0
91558 3+ 2.5+ 1+ 1+
28065B 0 1+ 0
28065D 3.5+ 2.5+, 3+ 3+, 3+ 2+, 3+ 0
28065C 0.5+ 3+, 3+
28065A 3+ 2+ 0

Immunohistochemical analysis using anti-coxsackievirus B horse polyclonal antibody on brain from control and archival EL cases. The same expressions for quantitation are used as in Table 1. Case numbers followed by letters indicate different blocks from the same case. When tests were repeated, the two results are indicated in the same box.

Dourmashkin et al.

Dourmashkin et al. BMC Infectious Diseases 2012 12:136   doi:10.1186/1471-2334-12-136

Open Data